Hormonal markers of stress response following interruption of selective serotonin reuptake inhibitor treatment

Psychoneuroendocrinology

Volumn 25, Issue 2, 2000, Pages 169-177

  Michelson, David ^a,b   Amsterdam, Jay ^c   Apter, Jeffrey ^d   Fava, Maurizio ^e   Londborg, Peter ^f   Tamura, Roy ^a   Pagh, Lisa ^a  

^a ELI LILLY AND COMPANY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d Princeton Biomedical Research   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f Seattle Clinical Research Center   (United States)

Author keywords

Fluoxetine; Paroxetine; Sertraline; SSRI; Stress response; Treatment interruption

Indexed keywords

BIOCHEMICAL MARKER; FLUOXETINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SOMATOMEDIN C;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG METABOLISM; DRUG WITHDRAWAL; FEMALE; HEART RATE; HUMAN; HYPOTHESIS; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGULATORY MECHANISM; STRESS; WITHDRAWAL SYNDROME;

EID: 0033991337     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(99)00046-3     Document Type: Article

References (16)

1. Brady L.S., Gold P.W., Herkenham M., Lynn A., Whitfield Jr H.J. The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications. Brain Res. 572:1992;117-125.
2. Chrousos G.P., Gold P.W. The concepts of stress and stress system disorder. Overview of physical and behavioral homeostasis. J. Am. Med. Assoc. 267:1992;1244-1252.
3. Coupland N.J., Bell C.J., Potokar J.P. Serotonin reuptake inhibitor withdrawal. J. Clin. Psychopharmacol. 16:1996;356-362.
4. Gold P.W., Goodwin F.K., Chrousos G.P. Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress. N. Engl. J. Med. 319:1988;413-420.
5. Gold P.W., Goodwin F.K., Chrousos G.P. Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress. N. Engl. J. Med. 319:1988;348-353.
6. Haddad P., Lejoyeux M., Young A. Antidepressant discontinuation reactions. Br. Med. J. 316:1998;1105-1106.
7. Hamilton, M.A., 1967. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 278-296.
8. Le Roith D. Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. N. Engl. J. Med. 336:1997;633-640.
9. Lesch K.P., Laux G., Pfuller H., Erb A., Beckmann H. Growth hormone (GH) response to GH-releasing hormone in depression. J. Clin. Endocrinol. Metab. 65:1987;1278-1281.
10. Melia K.R., Nestler E.J., Duman R.S. Chronic imipramine treatment normalizes levels of tyrosine hydroxylase in the locus coeruleus of chronically stressed rats. Psychopharmacology. 108:1992;23-26.
11. Mendlewicz J., Linkowski P., Kerkhofs M. et al. Diurnal hypersecretion of growth hormone in depression. J. Clin. Endocrinol. Metab. 60:1985;505-512.
12. Michelson D., Galliven E., Hill L., Demitrack M., Chrousos G., Gold P. Chronic imipramine is associated with diminished hypothalamic- pituitary-adrenal axis responsivity in healthy humans. J. Clin. Endocrinol. Metab. 82:1997;2601-2606.
13. Rosenbaum J.F., Fava M., Hoog S.L., Ascroft R.C., Krebs W.B. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biolog. Psychiatry. 44:1998;77-87.
14. Schatzberg A.F., Haddad P., Kaplan E.M. et al. Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. Discontinuation consensus panel. J. Clin. Psychiatry. 58(Suppl 7):1997;23-27.
15. Spielberger, C.D., 1983. Manual for the state trait anxiety inventory. Consulting Psychologists, Palo, CA.
16. Zajecka J., Fawcett J., Amsterdam J. et al. Safety of abrupt discontinuation of fluoxetine: a randomized, placebo-controlled study. J. Clin. Psychopharmacol. 18:1998;193-197.